RECENT NEWS

Point-of-care diagnostics company LumiraDX has received $14.2 million in grants from the Bill & Melinda Gates Foundation for ongoing development of its point-of-care molecular tuberculosis (TB) testing system.

SEHTA and IVDeology are presenting a free-to-attend webinar to start-up companies who want to know more about quality management systems and how they impact an organisation.

The Government has announced over £175 million of funding to create the most advanced genomic healthcare system in the world, helping to save lives and improve health outcomes.

The December 2022 edition of Pathology in Practice has been published and is available to read online.

The Native Antigen Company (part of LGC Clinical Diagnostics) has announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein (SEBOV GP).

Students in the College of Health and Life Sciences at Aston University are to benefit from a major £4.8 million investment in new facilities funded by the Office for Students to further expand and develop the University’s suite of state-of-the-art healthcare simulation and laboratory facilities.

Labcorp has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.

The UK-wide awards ceremony of pathology provider SYNLAB has shone a spotlight on those helping to deliver vital medical diagnostic services to millions of patients.

Bio-Rad Laboratories has announced an expanded portfolio of independent quality controls (QC) products, now including InteliQ and Liquichek compact vials, for the Abbott Alinity ci-series integrated clinical chemistry and immunoassay testing instruments.

‘ISO 15189:2022 Medical Laboratories – Requirements for quality and competence’ was published on 6 December 2022 by UKAS.

Roche has announced that its Elecsys beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys Phospho-Tau (181P) CSF (pTau181) assays have received US Food and Drug Administration (FDA) 510(k) clearance.

Mast Group has announced a multi-region agreement with Nanōmix Corporation to distribute the mobile point-of-care eLab system in the United Kingdom, Germany, France, Ireland and South Africa.

AI cancer diagnostics firm Ibex Medical and Source LDPath have announced a new agreement to expand the deployment of artificial intelligence to the entire pathology network at Source.

Agilent Technologies has opened a new Customer Experience Center (CEC) in Lexington, MA, focused on solutions from Agilent genomics and diagnostics product portfolios.

The IBMS has submitted evidence to the Public Accounts Committee's inquiry into managing NHS backlogs and waiting times, as part of its commitment to supporting the profession from the ground up and having an impact on government policy.

The Laboratory of Pathology at Dordrecht, Netherlands is to collaborate with PreciseDx by studying the performance of PreciseDx’s AI-driven Cancer Risk Stratification platform, confirming its accuracy of staging and role in the decision process.

BC Platforms has announced that, together with Finland’s Euformatics and Hungary’s Oncompass Medicine, the BCP-led partnership has been awarded a contract for the second phase of developing standardised oncology workflows for a consortium of seven leading central European hospitals, represented by the Medical University Graz.

BIOHIT HealthCare has announced a new partnership with Celltrion Healthcare UK, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to support patients with inflammatory bowel disease (IBD) and their healthcare providers.

Metrion Biosciences Limited has recently launched its high-throughput screening (HTS) capability, coinciding with the expansion of its state-of-the-art laboratory and office facilities.

Dudley’s laboratory implements the WinPath Enterprise laboratory information system and the latest version of ICE order communications and results reporting in a ‘big bang’ deployment